American Diabetes Association Pathway to Stop Diabetes: Harvard Pre-Proposal Deadline

American Diabetes Association Pathway to Stop DiabetesHarvard Pre-Proposal Deadline: June 26, 2022FAS/SEAS/OSP Deadline: July 25, 2022Sponsor Deadline: August 1, 2022Initiator Award Amount: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.Accelerator Award Amount: Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

Pathway to Stop Diabetes provides crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, management and cures for diabetes. This call for nominations will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease. Nominees are required to devote at least 75% of their total time and effort to research during the funding period. In addition, nominees must devote a specific required percent effort for each of the award types.

There are two types of awards granted through this program:

1. Initiator Award: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. 75-100% effort is required in Phase 1 and 50-75% effort in Phase 2.
2. Accelerator Award: This award is designed to support exceptional, independent early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, sustainable diabetes research programs. Awards are available to early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K, U or R awards, including an initial R01/U01) but must not have applied for (regardless of outcome), or received, an R01/U01 renewal or a second R01/U01 award. 25-50% effort is required.

The Harvard University Cambridge campus may submit only one proposal to either the Accelerator or Initiator opportunities. In order to be considered for the nomination, interested applicants must first submit an internal pre-proposal to the Office of the Vice Provost for Research. The Accelerator application can be found at https://bit.ly/3ynQr5O and the Initiator application can be found at https://bit.ly/3Fy7NyE.